Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

The Controversy of Contrast-Induced Nephropathy With Intravenous Contrast: What Is the Risk?

Rudnick MR, Leonberg-Yoo AK, Litt HI, Cohen RM, Hilton S, Reese PP.

Am J Kidney Dis. 2019 Aug 28. pii: S0272-6386(19)30844-3. doi: 10.1053/j.ajkd.2019.05.022. [Epub ahead of print] Review.

PMID:
31473019
2.

Lactic Acidosis and The Role of Sodium Bicarbonate: A Narrative Opinion.

Rudnick MR, Blair GJ, Kuschner WG, Barr J.

Shock. 2019 Jul 16. doi: 10.1097/SHK.0000000000001415. [Epub ahead of print]

PMID:
31318832
3.

Bilateral Renal Infarctions During the Use of Sumatriptan.

Abramovitz B, Leonberg-Yoo A, Bahrainwala JZ, Litt H, Rudnick MR.

Kidney Int Rep. 2018 May 16;3(5):1233-1236. doi: 10.1016/j.ekir.2018.05.003. eCollection 2018 Sep. No abstract available.

4.

Tobacco Use: A Chronic Kidney Disease Accelerant.

Leonberg-Yoo AK, Rudnick MR.

Am J Nephrol. 2017;46(4):257-259. doi: 10.1159/000481209. Epub 2017 Sep 21. No abstract available.

5.

Use of Radiocontrast Agents in CKD and ESRD.

Bahrainwala JZ, Leonberg-Yoo AK, Rudnick MR.

Semin Dial. 2017 Jul;30(4):290-304. doi: 10.1111/sdi.12593. Epub 2017 Apr 5. Review.

PMID:
28382626
6.

Hemodynamic monitoring during liver transplantation: A state of the art review.

Rudnick MR, Marchi LD, Plotkin JS.

World J Hepatol. 2015 Jun 8;7(10):1302-11. doi: 10.4254/wjh.v7.i10.1302. Review.

7.

Relative Nephrotoxicity of Different Contrast Media.

Aqeel I, Garcha AS, Rudnick MR.

Interv Cardiol Clin. 2014 Jul;3(3):349-356. doi: 10.1016/j.iccl.2014.04.001. Epub 2014 Jun 28. Review.

PMID:
28582219
8.

How does the nephrologist manage an LVAD patient on chronic maintenance dialysis?

Patel AM, Eduardo Rame J, Rudnick MR.

Semin Dial. 2014 May-Jun;27(3):284-8. doi: 10.1111/sdi.12229. Epub 2014 Mar 21. No abstract available.

PMID:
24650366
9.

Renal failure in patients with left ventricular assist devices.

Patel AM, Adeseun GA, Ahmed I, Mitter N, Rame JE, Rudnick MR.

Clin J Am Soc Nephrol. 2013 Mar;8(3):484-96. doi: 10.2215/CJN.06210612. Epub 2012 Oct 11. Review.

10.

Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: the Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial.

Rudnick MR, Davidson C, Laskey W, Stafford JL, Sherwin PF; VALOR Trial Investigators.

Am Heart J. 2008 Oct;156(4):776-82.

PMID:
18946896
11.

Clinical significance and preventive strategies for contrast-induced nephropathy.

Sterling KA, Tehrani T, Rudnick MR.

Curr Opin Nephrol Hypertens. 2008 Nov;17(6):616-23. doi: 10.1097/MNH.0b013e32830f45a3. Review.

PMID:
18941356
12.

Contrast-induced nephropathy: is the picture any clearer?

Rudnick MR, Goldfarb S, Tumlin J.

Clin J Am Soc Nephrol. 2008 Jan;3(1):261-2. Epub 2007 Dec 12. Review. No abstract available.

13.

Contrast-induced nephropathy: how it develops, how to prevent it.

Rudnick MR, Kesselheim A, Goldfarb S.

Cleve Clin J Med. 2006 Jan;73(1):75-80, 83-7. Review.

PMID:
16444919
14.

Hemodialysis-related venous stenosis: treatment with ultrahigh-pressure angioplasty balloons.

Trerotola SO, Stavropoulos SW, Shlansky-Goldberg R, Tuite CM, Kobrin S, Rudnick MR.

Radiology. 2004 Apr;231(1):259-62.

PMID:
15068951
15.
16.

Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism.

Wang A, Holcslaw T, Bashore TM, Freed MI, Miller D, Rudnick MR, Szerlip H, Thames MD, Davidson CJ, Shusterman N, Schwab SJ.

Kidney Int. 2000 Apr;57(4):1675-80.

17.

Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac disease.

Berns JS, Rudnick MR, Cohen RM, Bower JD, Wood BC.

Kidney Int. 1999 Jul;56(1):253-60.

18.

Bromfenac disposition in patients with impaired kidney function.

Ermer JC, Boni JP, Cevallos WH, DeCleene S, Burghart P, Rudnick MR, Fruncillo RJ, Berns JS, Cohen RM.

Clin Pharmacol Ther. 1997 Mar;61(3):312-8.

PMID:
9084456
19.

Contrast media-associated nephrotoxicity.

Rudnick MR, Berns JS, Cohen RM, Goldfarb S.

Semin Nephrol. 1997 Jan;17(1):15-26. Review.

PMID:
9000546
20.

Contrast media-associated nephrotoxicity.

Rudnick MR, Berns JS, Cohen RM, Goldfarb S.

Curr Opin Nephrol Hypertens. 1996 Mar;5(2):127-33. Review.

PMID:
8744533
21.

Severe, irreversible renal failure after ifosfamide treatment. A clinicopathologic report of two patients.

Berns JS, Haghighat A, Staddon A, Cohen RM, Schmidt R, Fisher S, Rudnick MR, Tomaszewski JE.

Cancer. 1995 Aug 1;76(3):497-500.

PMID:
8625132
22.

Health-related quality of life associated with recombinant human erythropoietin therapy for predialysis chronic renal disease patients.

Revicki DA, Brown RE, Feeny DH, Henry D, Teehan BP, Rudnick MR, Benz RL.

Am J Kidney Dis. 1995 Apr;25(4):548-54.

PMID:
7702049
23.

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study.

Rudnick MR, Goldfarb S, Wexler L, Ludbrook PA, Murphy MJ, Halpern EF, Hill JA, Winniford M, Cohen MB, VanFossen DB.

Kidney Int. 1995 Jan;47(1):254-61.

24.

Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients.

Roth D, Smith RD, Schulman G, Steinman TI, Hatch FE, Rudnick MR, Sloand JA, Freedman BI, Williams WW Jr, Shadur CA, et al.

Am J Kidney Dis. 1994 Nov;24(5):777-84.

PMID:
7977319
25.

Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review.

Rudnick MR, Berns JS, Cohen RM, Goldfarb S.

Am J Kidney Dis. 1994 Oct;24(4):713-27. Review.

PMID:
7942832
26.

Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity.

Goldfarb S, Spinler S, Berns JS, Rudnick MR.

Invest Radiol. 1993 Nov;28 Suppl 5:S7-10; discussion S11-2. Review.

PMID:
8282507
27.

Multicenter trial of ionic versus nonionic contrast media for cardiac angiography. The Iohexol Cooperative Study.

Hill JA, Winniford M, Cohen MB, Van Fossen DB, Murphy MJ, Halpern EF, Ludbrook PA, Wexler L, Rudnick MR, Goldfarb S.

Am J Cardiol. 1993 Oct 1;72(11):770-5.

PMID:
8213508
29.

Hypoglycemia with hyperinsulinemia in a chronic hemodialysis patient following parathyroidectomy.

Nadkarni M, Berns JS, Rudnick MR, Cohen RM.

Nephron. 1992;60(1):100-3.

PMID:
1738397
30.

Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.

Berns JS, Rudnick MR, Cohen RM.

Am J Kidney Dis. 1991 Jul;18(1):143. No abstract available.

PMID:
2063850
31.

Renal aspects of therapy for human immunodeficiency virus and associated opportunistic infections.

Berns JS, Cohen RM, Stumacher RJ, Rudnick MR.

J Am Soc Nephrol. 1991 Mar;1(9):1061-80. Review.

32.

Removal of myoglobin by CAVH-D in traumatic rhabdomyolysis.

Berns JS, Cohen RM, Rudnick MR.

Am J Nephrol. 1991;11(1):73. No abstract available.

PMID:
2048582
33.

New approaches to the diagnosis of renovascular hypertension.

Maxwell MH, Rudnick MR, Waks AU.

Adv Nephrol Necker Hosp. 1985;14:285-304. Review. No abstract available.

PMID:
3919536
34.

Thrombotic microangiopathy and renal failure associated with antineoplastic chemotherapy.

Jackson AM, Rose BD, Graff LG, Jacobs JB, Schwartz JH, Strauss GM, Yang JP, Rudnick MR, Elfenbein IB, Narins RG.

Ann Intern Med. 1984 Jul;101(1):41-4.

PMID:
6203452
35.

Correction of drug binding defects in uremia in vitro by anion exchange resin treatment.

Lichtenwalner DM, Suh B, Lorber B, Rudnick MR, Craig WA.

Biochem Pharmacol. 1982 Nov 1;31(21):3483-7.

PMID:
7150368
36.

Diagnostic strategies in disorders of fluid, electrolyte and acid-base homeostasis.

Narins RG, Jones ER, Stom MC, Rudnick MR, Bastl CP.

Am J Med. 1982 Mar;72(3):496-520. Review.

PMID:
7036739
37.

Cimetidine-induced acute renal failure.

Rudnick MR, Bastl CP, Elfenbein IB, Sirota RA, Yudis M, Narins RG.

Ann Intern Med. 1982 Feb;96(2):180-2. No abstract available.

PMID:
7059066
38.

Partial purification and characterization of the drug-binding-defect inducer in uremia.

Lichtenwalner DM, Suh B, Lorber B, Rudnick MR, Craig WA.

J Lab Clin Med. 1981 Jan;97(1):72-81.

PMID:
7452082
39.
40.

The kidney in health and disease: XVIII: lactic acidosis and the elevated anion gap (II).

Narins RG, Rudnick MR, Bastl CP.

Hosp Pract. 1980 Jun;15(6):91-8.

PMID:
7399487
41.

Lactic acidosis and the elevated anion gap (I).

Narins RG, Rudnick MR, Bastl CP.

Hosp Pract. 1980 May;15(5):125-9, 133-6. No abstract available.

PMID:
6768669
42.

Case 38-1979: Ethylene glycol poisoning.

Narins RG, Rudnick MR, Bastl CP.

N Engl J Med. 1980 Feb 21;302(8):466. No abstract available.

PMID:
6766204
43.

Effects of placebo versus guanabenz on hypertensive out-patients.

Walker BR, Schneider BE, Rudnick MR, Gold JA.

J Int Med Res. 1980;8(5):303-13.

PMID:
7418949
44.

Acute massive hydrothorax complicating peritoneal dialysis, report of 2 cases and a review of the literature.

Rudnick MR, Coyle JF, Beck LH, McCurdy DK.

Clin Nephrol. 1979 Jul;12(1):38-44.

PMID:
477054

Supplemental Content

Loading ...
Support Center